secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADIAL PHARMACEUTICALS, INC. (ADIL)
CIK:        0001513525
Form:       8-K
Filed at:   2024-04-18T23:59:59+00:00
Accession:  0001213900-24-034186
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Adial Pharmaceuticals enters ATM equity offering of up to $4.28M with H.C. Wainwright
--------------------------------------------------------------------------------

- At-the-market offering of common stock up to $4,283,650 based on Form S-3 limitations.
- Sales agent H.C. Wainwright receives 3% commission on gross proceeds from each sale.
- Company to reimburse Wainwright up to $50,000 in expenses, plus $2,500 per due diligence update.
- Offering continues until all shares sold or the agreement is terminated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1513525/000121390024034186/0001213900-24-034186-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1513525/000121390024034186/ea0203748-8k_adial.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-034186

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer